Cargando…
Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
BACKGROUND: Several clinical trials reported that clopidogrel was superior to aspirin in secondary stroke prevention by reducing the risk of major adverse cardiovascular events (MACE). We aimed to compare the efficacy of clopidogrel with aspirin in reducing one-year risk of MACE based on real-world...
Autores principales: | Vidyanti, Amelia Nur, Chan, Lung, Lin, Cheng-Li, Muo, Chih-Hsin, Hsu, Chung Y., Chen, You-Chia, Wu, Dean, Hu, Chaur-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715172/ https://www.ncbi.nlm.nih.gov/pubmed/31465467 http://dx.doi.org/10.1371/journal.pone.0221750 |
Ejemplares similares
-
Correction: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
por: Vidyanti, Amelia Nur, et al.
Publicado: (2020) -
Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
por: Lee, Meng, et al.
Publicado: (2014) -
Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004) -
Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World Data
por: Chi, Nai‐Fang, et al.
Publicado: (2018) -
Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel
por: Ge, Lihong, et al.
Publicado: (2019)